Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

US commercial-stage drugmaker Corcept Therapeutics (Nasdaq: CORT) has presented results from its DAZALS study of dazucorilant ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

Quantum Metric, the customer-driven digital analytics platform, today celebrates the one-year anniversary of its generative AI-powered solution, Felix AI.  Launched in April 2024, Felix AI has quickly ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Members of the HEALEY ALS writing committee are listed at the end of the Article and HEALEY ALS Platform Trial Study Group members are listed in the appendix (pp 201–06) ...

Peoria native Jeffrey Birkel, diagnosed with ALS, completed the 2025 Boston Marathon with his sons. This marathon marked a full-circle moment for the family, as running has always been a shared ...

ALS stands for amyotrophic lateral sclerosis and is also known as Lou Gehrig's disease. Stephen Hawking lived with ALS for 55 years and advocated for research and helped bring awareness to the disease ...